BG
ALDR
Bellevue Group’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,492,466
| Closed | -$84.7M | – | 230 |
|
|
2019
Q3 | $84.7M | Buy |
4,492,466
+373,660
| +9% | +$7.05M | 1.58% | 17 |
|
|
2019
Q2 | $48.5M | Buy |
4,118,806
+2,832,058
| +220% | +$33.3M | 0.83% | 34 |
|
|
2019
Q1 | $17.6M | Buy |
1,286,748
+162,935
| +14% | +$2.22M | 0.97% | 33 |
|
|
2018
Q4 | $11.5M | Buy |
1,123,813
+218,559
| +24% | +$2.24M | 0.76% | 39 |
|
|
2018
Q3 | $15.1M | Buy |
905,254
+146,290
| +19% | +$2.44M | 0.96% | 35 |
|
|
2018
Q2 | $12M | Buy |
758,964
+58,500
| +8% | +$924K | 1.02% | 37 |
|
|
2018
Q1 | $8.9M | Buy |
700,464
+669,864
| +2,189% | +$8.51M | 0.88% | 45 |
|
|
2017
Q4 | $350K | Sell |
30,600
-2,400
| -7% | -$27.5K | 0.04% | 131 |
|
|
2017
Q3 | $404K | Hold |
33,000
| – | – | 0.04% | 129 |
|
|
2017
Q2 | $378K | Hold |
33,000
| – | – | 0.04% | 129 |
|
|
2017
Q1 | $686K | Hold |
33,000
| – | – | 0.09% | 113 |
|
|
2016
Q4 | $686K | Hold |
33,000
| – | – | 0.14% | 100 |
|
|
2016
Q3 | $1.08M | Hold |
33,000
| – | – | 0.2% | 94 |
|
|
2016
Q2 | $824K | Hold |
33,000
| – | – | 0.16% | 101 |
|
|
2016
Q1 | $808K | Buy |
+33,000
| New | +$808K | 0.15% | 100 |
|